Upstate Clinical Research Associates
Welcome,         Profile    Billing    Logout  
 4 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wild, James
PROSPER-FM, NCT05243511: Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

Completed
3
275
US
Digital ACT, Digital Symptom Tracker
Swing Therapeutics, Inc.
Fibromyalgia
05/23
05/23
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection

Completed
2
63
US
TNX-102 SL, Placebo SL Tablet
Tonix Pharmaceuticals, Inc.
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID
07/23
07/23
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

Completed
2
797
NA
ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline
AEON Biopharma, Inc., PPD
Migraine
06/24
08/24
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain

Terminated
2
314
Europe, Canada, Japan, US, RoW
GSK3858279, Placebo
GlaxoSmithKline
Pain, Osteoarthritis, Knee
08/24
12/24
Strombach, Amy
NCT05217927 / 2021-005239-22: Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Completed
4
698
Europe, Canada, US
Rimegepant 75mg daily dosing, Rimegepant 75mg every other day dosing, Placebo comparator dosing
Pfizer, Biohaven Pharmaceuticals Holding Company Limited, Pfizer Inc.
Migraine
10/24
12/24
NCT05139121: Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Completed
3
1319
Canada, US
MR-100A-01, Transdermal contraceptive delivery system
Mylan Technologies Inc., Mylan Inc.
Contraception
01/25
01/25
NCT04804033: A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Terminated
2/3
1753
US
BHV-3500 (zavegepant), Placebo
Pfizer
Migraine
03/24
03/24
NCT06816433: Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002

Not yet recruiting
2
200
US
Intervention D SLS-002, Ketamine, Intervention D Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05948553: Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine

Recruiting
2
200
US
Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05422612: Department of Defense PTSD Adaptive Platform Trial - Master Protocol

Recruiting
2
800
US
Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo, Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo, Intervention C Daridorexant, Intervention C Placebo, Intervention D SLS-002, Intervention D Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05948540: Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Active, not recruiting
2
200
US
Intervention C Daridorexant, Intervention C Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
Briner, Kaylie
NCT06000410: A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients with Osteoarthritis of the Knee

Active, not recruiting
3
474
US
Amniotic Suspension Allograft, Placebo
Organogenesis
Knee Osteoarthritis
09/25
03/26
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection

Completed
2
63
US
TNX-102 SL, Placebo SL Tablet
Tonix Pharmaceuticals, Inc.
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID
07/23
07/23
NCT05796765: Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis

Terminated
2
43
US
Micronized DHACM 40 mg, Micronized DHACM 100 mg, Saline
MiMedx Group, Inc., Rho, Inc., United BioSource, LLC, NBCD A/S
Knee Osteoarthritis
12/23
12/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wild, James
PROSPER-FM, NCT05243511: Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

Completed
3
275
US
Digital ACT, Digital Symptom Tracker
Swing Therapeutics, Inc.
Fibromyalgia
05/23
05/23
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection

Completed
2
63
US
TNX-102 SL, Placebo SL Tablet
Tonix Pharmaceuticals, Inc.
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID
07/23
07/23
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

Completed
2
797
NA
ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline
AEON Biopharma, Inc., PPD
Migraine
06/24
08/24
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain

Terminated
2
314
Europe, Canada, Japan, US, RoW
GSK3858279, Placebo
GlaxoSmithKline
Pain, Osteoarthritis, Knee
08/24
12/24
Strombach, Amy
NCT05217927 / 2021-005239-22: Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Completed
4
698
Europe, Canada, US
Rimegepant 75mg daily dosing, Rimegepant 75mg every other day dosing, Placebo comparator dosing
Pfizer, Biohaven Pharmaceuticals Holding Company Limited, Pfizer Inc.
Migraine
10/24
12/24
NCT05139121: Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Completed
3
1319
Canada, US
MR-100A-01, Transdermal contraceptive delivery system
Mylan Technologies Inc., Mylan Inc.
Contraception
01/25
01/25
NCT04804033: A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Terminated
2/3
1753
US
BHV-3500 (zavegepant), Placebo
Pfizer
Migraine
03/24
03/24
NCT06816433: Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002

Not yet recruiting
2
200
US
Intervention D SLS-002, Ketamine, Intervention D Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05948553: Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine

Recruiting
2
200
US
Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05422612: Department of Defense PTSD Adaptive Platform Trial - Master Protocol

Recruiting
2
800
US
Intervention A Fluoxetine Hydrochloride (HCl), Intervention A Placebo, Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo, Intervention C Daridorexant, Intervention C Placebo, Intervention D SLS-002, Intervention D Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
NCT05948540: Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Active, not recruiting
2
200
US
Intervention C Daridorexant, Intervention C Placebo
Global Coalition for Adaptive Research, U.S. Army Medical Research and Development Command, PPD DEVELOPMENT, LP, Berry Consultants, Idorsia Pharmaceuticals Ltd., Cambridge Cognition Ltd, Citeline
Post Traumatic Stress Disorder
03/26
09/26
Briner, Kaylie
NCT06000410: A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients with Osteoarthritis of the Knee

Active, not recruiting
3
474
US
Amniotic Suspension Allograft, Placebo
Organogenesis
Knee Osteoarthritis
09/25
03/26
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection

Completed
2
63
US
TNX-102 SL, Placebo SL Tablet
Tonix Pharmaceuticals, Inc.
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID
07/23
07/23
NCT05796765: Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis

Terminated
2
43
US
Micronized DHACM 40 mg, Micronized DHACM 100 mg, Saline
MiMedx Group, Inc., Rho, Inc., United BioSource, LLC, NBCD A/S
Knee Osteoarthritis
12/23
12/23

Download Options